The Biological Input Layer forms the scientific foundation of the MycoResin™ system. It focuses on the structured design, validation, and stabilization of fungal consortia capable of safely stimulating resin-associated defense pathways in target species.
Core Components:
- Strain Identification & Selection Framework
Candidate fungal strains are evaluated based on ecological compatibility with Aquilaria spp., signaling capacity, colonization behavior, and non-lethal interaction profiles. Selection prioritizes strains that trigger biochemical defense responses without causing aggressive pathogenic damage. - Compatibility & Interaction Screening
Controlled laboratory assessments evaluate:- Host–fungal signaling dynamics
- Tissue response behavior
- Stability of interaction over time
- Absence of excessive vascular disruption
- Consortium Design Logic
Rather than relying on a single organism, the platform may utilize structured fungal groupings where complementary biological roles are observed, such as:- Signal initiation
- Defense amplification
- Metabolic pathway reinforcement
- Stability & Quality Assurance Controls
Each biological input batch undergoes identity verification, viability confirmation, and contamination safeguards prior to deployment. Documentation standards ensure traceability from preparation to field application. - Risk Mitigation Principles
The design philosophy emphasizes:- Controlled biological signaling
- Tree vitality preservation
- Environmental compatibility
- Non-synthetic, non-toxic alignment with ESG principles
This engineered fungal consortium layer transforms natural biological interactions into a structured, monitorable, and commercially deployable activation system while minimizing uncontrolled variability.